Pattern Pharma is a biopharmaceutical company with therapeutics that mobilize innate immunity to address the immune failures underpinning many diseases, with a particular focus on cancer.Pattern’s scientific cofounders showed that innate immune cells are activated by receptor clustering and discovered a patent-protected compound (PPI-100) which did this safely. Pattern’s focus is on deploying PPI-100 in the perioperative setting to address the 40% relapse rate in cancer patients 5 years after surgical resection.